sample_id	title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	characteristics_ch1.5	characteristics_ch1.6	characteristics_ch1.7	characteristics_ch1.8	characteristics_ch1.9	characteristics_ch1.10	characteristics_ch1.11	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	hyb_protocol	scan_protocol	data_processing	platform_id	contact_name	contact_email	contact_phone	contact_department	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	supplementary_file	data_row_count	%emphysema (f-950):ch1	%predicted dlco:ch1	%predicted fev1 (post-bd):ch1	%predicted fev1 (pre-bd):ch1	%predicted fvc (post-bd):ch1	%predicted fvc (pre-bd):ch1	age:ch1	disease state:ch1	gold stage:ch1	ild subtype:ch1	pneumocystis colonization:ch1	Sex:ch1	smoker?:ch1	group.x	PATIENT_ID	Tissue_Type	Gender	Age	Axial_distribution_of_emphysema	Axial_distribution_of_interstitial_process	Chemotherapy_for_cancer_Ever	Cigarette_smoking	Craniocaudal_distribution_of_interstitial_process	Do_you_usually_cough_like_this_on_most_days_for_three_consecutive_months_during_the_year	Do_you_usually_have_a_cough	FEV1_Pre_Bronchodilator_predicted_Categorical	First_degree_blood_relatives_developed_Asthma	First_degree_blood_relatives_developed_COPD	First_degree_blood_relatives_developed_Emphysema	Have_you_ever_lived_in_a_household_in_which_people_smoked	Major_Diagnosis_Final_Clinical	Major_Diagnosis_Final_Pathological	Severity_classification_of_DLCO_abnormality_Categorical	Spirometric_classification_of_COPD_Post_Only	Spirometric_classification_of_COPD_Pre_Post_Mixed	group
LT000216LL	LT000216LL_ILD	GSM1150365	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 70	%emphysema (f-950): 0.051	smoker?: 3-Never	%predicted fev1 (pre-bd): 56	%predicted fvc (pre-bd): 47	%predicted dlco: 36	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150365/suppl/GSM1150365_LT000216LL_ILD.txt.gz	15261	0.051	36	NA	56	NA	47	70	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	107993	Lung-LL	2-Female	70	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	3-Unknown	1-Yes	3-Unknown	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT001600RL	LT001600RL_ILD	GSM1149950	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 54	%emphysema (f-950): 1.903	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 40	%predicted fvc (pre-bd): 39	%predicted dlco: 16	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149950/suppl/GSM1149950_LT001600RL_ILD.txt.gz	15261	1.903	16	NA	40	NA	39	54	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	38477	Lung-RL	1-Male	54	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT002410RM	LT002410RM_ILD	GSM1150367	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 52	%emphysema (f-950): 0.03	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 56	%predicted fvc (pre-bd): 51	%predicted fev1 (post-bd): 60	%predicted fvc (post-bd): 53	%predicted dlco: 63	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150367/suppl/GSM1150367_LT002410RM_ILD.txt.gz	15261	0.03	63	60	56	53	51	52	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	233433	Lung-RM	1-Male	52	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT004173LL	LT004173LL_ILD	GSM1149952	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 67	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 26	%predicted fvc (pre-bd): 21	%predicted dlco: 17	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149952/suppl/GSM1149952_LT004173LL_ILD.txt.gz	15261	NA	17	NA	26	NA	21	67	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	200906	Lung-LL	1-Male	67	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	4-<30%	1-Yes	2-No	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT006946RM	LT006946RM_ILD	GSM1150370	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	smoker?: 3-Never	%predicted fev1 (pre-bd): 66	%predicted fvc (pre-bd): 56	%predicted dlco: 69	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150370/suppl/GSM1150370_LT006946RM_ILD.txt.gz	15261	NA	69	NA	66	NA	56	68	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	25982	Lung-RM	1-Male	68	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT012933RL	LT012933RL_ILD	GSM1150372	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 68	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 90	%predicted fvc (pre-bd): 83	%predicted dlco: 95	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150372/suppl/GSM1150372_LT012933RL_ILD.txt.gz	15261	NA	95	NA	90	NA	83	68	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	42170	Lung-RL	2-Female	68	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	1-Yes	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT017533RM	LT017533RM_ILD	GSM1150375	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 64	smoker?: 3-Never	%predicted fev1 (pre-bd): 42	%predicted fvc (pre-bd): 42	%predicted fev1 (post-bd): 43	%predicted fvc (post-bd): 42	%predicted dlco: 31	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150375/suppl/GSM1150375_LT017533RM_ILD.txt.gz	15261	NA	31	43	42	42	42	64	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	128038	Lung-RM	1-Male	64	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	3-30-50%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT019699RL	LT019699RL_ILD	GSM1150377	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 64	%emphysema (f-950): 0.196	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 101	%predicted fvc (pre-bd): 99	%predicted dlco: 71	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150377/suppl/GSM1150377_LT019699RL_ILD.txt.gz	15261	0.196	71	NA	101	NA	99	64	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	250295	Lung-RL	2-Female	64	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	1->=80%	1-Yes	3-Unknown	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT020259LL	LT020259LL_ILD	GSM1150183	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 43	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 65	%predicted fvc (pre-bd): 69	%predicted fev1 (post-bd): 69	%predicted fvc (post-bd): 72	%predicted dlco: 92	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150183/suppl/GSM1150183_LT020259LL_ILD.txt.gz	15261	NA	92	69	65	72	69	43	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	115543	Lung-LL	2-Female	43	1-None	1-None	2-No	2-Ever (>100)	1-None	1-Yes	1-Yes	2-50-80%	2-No	1-Yes	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT024857LU	LT024857LU_ILD	GSM1149959	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 55	%emphysema (f-950): 0.443	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 94	%predicted fvc (pre-bd): 94	%predicted dlco: 58	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149959/suppl/GSM1149959_LT024857LU_ILD.txt.gz	15261	0.443	58	NA	94	NA	94	55	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	128540	Lung-LU	1-Male	55	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT026534RL	LT026534RL_ILD	GSM1150384	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 73	%emphysema (f-950): 0.121	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 90	%predicted fvc (pre-bd): 80	%predicted dlco: 50	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150384/suppl/GSM1150384_LT026534RL_ILD.txt.gz	15261	0.121	50	NA	90	NA	80	73	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	85034	Lung-RL	2-Female	73	1-None	2-Peripheral/Subpleural	2-No	3-Never	2-Upper lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT030347RL	LT030347RL_ILD	GSM1150385	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 79	%emphysema (f-950): 0.405	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 95	%predicted fvc (pre-bd): 96	%predicted fev1 (post-bd): 96	%predicted fvc (post-bd): 97	%predicted dlco: 68	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150385/suppl/GSM1150385_LT030347RL_ILD.txt.gz	15261	0.405	68	96	95	97	96	79	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	145177	Lung-RL	1-Male	79	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT033422RL	LT033422RL_ILD	GSM1150191	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 64	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 93	%predicted fvc (pre-bd): 84	%predicted fev1 (post-bd): 96	%predicted fvc (post-bd): 83	%predicted dlco: 71	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150191/suppl/GSM1150191_LT033422RL_ILD.txt.gz	15261	NA	71	96	93	83	84	64	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	113369	Lung-RL	1-Male	64	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT036383LL	LT036383LL_ILD	GSM1150387	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 57	smoker?: 3-Never	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 59	%predicted dlco: 43	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150387/suppl/GSM1150387_LT036383LL_ILD.txt.gz	15261	NA	43	NA	69	NA	59	57	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	169507	Lung-LL	1-Male	57	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse		2-No	2-50-80%	3-Unknown	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT039091RL	LT039091RL_ILD	GSM1150196	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 85	%predicted fvc (pre-bd): 74	%predicted dlco: 33	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150196/suppl/GSM1150196_LT039091RL_ILD.txt.gz	15261	NA	33	NA	85	NA	74	62	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	110355	Lung-RL	1-Male	62	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	1->=80%	3-Unknown	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT041723RL	LT041723RL_ILD	GSM1150197	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 54	%emphysema (f-950): 0.43	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 101	%predicted fvc (pre-bd): 82	%predicted dlco: 65	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150197/suppl/GSM1150197_LT041723RL_ILD.txt.gz	15261	0.43	65	NA	101	NA	82	54	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	204404	Lung-RL	1-Male	54	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT042151RL	LT042151RL_ILD	GSM1150198	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 94	%predicted fvc (pre-bd): 91	%predicted fev1 (post-bd): 95	%predicted fvc (post-bd): 90	%predicted dlco: 72	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150198/suppl/GSM1150198_LT042151RL_ILD.txt.gz	15261	NA	72	95	94	90	91	69	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	74891	Lung-RL	1-Male	69	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse		2-No	1->=80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT046539RL	LT046539RL_ILD	GSM1150390	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 45	%emphysema (f-950): 0.063	smoker?: 3-Never	%predicted fev1 (pre-bd): 70	%predicted fvc (pre-bd): 65	%predicted dlco: 51	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150390/suppl/GSM1150390_LT046539RL_ILD.txt.gz	15261	0.063	51	NA	70	NA	65	45	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	7369	Lung-RL	2-Female	45	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT047521RL	LT047521RL_ILD	GSM1149974	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 68	%emphysema (f-950): 0.013	smoker?: 3-Never	%predicted fev1 (pre-bd): 42	%predicted fvc (pre-bd): 39	%predicted fev1 (post-bd): 47	%predicted fvc (post-bd): 42	%predicted dlco: 67	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149974/suppl/GSM1149974_LT047521RL_ILD.txt.gz	15261	0.013	67	47	42	42	39	68	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	98303	Lung-RL	2-Female	68	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT049193LU	LT049193LU_ILD	GSM1149977	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 74	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 104	%predicted fvc (pre-bd): 89	%predicted dlco: 57	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149977/suppl/GSM1149977_LT049193LU_ILD.txt.gz	15261	NA	57	NA	104	NA	89	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	84004	Lung-LU	2-Female	74	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	3-Unknown	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT050079RL	LT050079RL_ILD	GSM1150392	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	gold stage: 2-Moderate COPD	smoker?: 3-Never	%predicted fev1 (pre-bd): 75	%predicted fvc (pre-bd): 82	%predicted fev1 (post-bd): 71	%predicted fvc (post-bd): 78	%predicted dlco: 57	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150392/suppl/GSM1150392_LT050079RL_ILD.txt.gz	15261	NA	57	71	75	78	82	68	Interstitial lung disease	2-Moderate COPD	2-UIP/IPF	NA	1-Male	3-Never	IPF	97345	Lung-RL	1-Male	68	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	2-Moderate COPD	2-Moderate COPD	IPF
LT052751LL	LT052751LL_CTRL	GSM1149981	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 82	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 96	%predicted fvc (pre-bd): 97						total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149981/suppl/GSM1149981_LT052751LL_CTRL.txt.gz	15261	NA	NA	NA	96	NA	97	82	Control	0-At Risk	NA	NA	2-Female	2-Ever (>100)	control	190535	Lung-LL	2-Female	82	1-None	1-None	2-No	2-Ever (>100)	1-None		2-No	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control			0-At Risk	control
LT056301LL	LT056301LL_ILD	GSM1149984	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 73	%emphysema (f-950): 0.69	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 83	%predicted fvc (pre-bd): 72	%predicted dlco: 56	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149984/suppl/GSM1149984_LT056301LL_ILD.txt.gz	15261	0.69	56	NA	83	NA	72	73	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	94384	Lung-LL	1-Male	73	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT056464LL	LT056464LL_ILD	GSM1149985	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 54	smoker?: 3-Never	%predicted fev1 (pre-bd): 40	%predicted fvc (pre-bd): 39	%predicted dlco: 25	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149985/suppl/GSM1149985_LT056464LL_ILD.txt.gz	15261	NA	25	NA	40	NA	39	54	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	5610	Lung-LL	1-Male	54	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	2-No	1-Yes	3-30-50%	1-Yes	2-No	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT058319LU	LT058319LU_CTRL	GSM1150394	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 1-Male	age: 71	%emphysema (f-950): 0.513	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 114	%predicted fvc (pre-bd): 106	%predicted dlco: 82				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150394/suppl/GSM1150394_LT058319LU_CTRL.txt.gz	15261	0.513	82	NA	114	NA	106	71	Control	0-At Risk	NA	NA	1-Male	2-Ever (>100)	control	289390	Lung-LU	1-Male	71	3-Central/Axial	1-None	2-No	2-Ever (>100)	1-None	2-No	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)		0-At Risk	control
LT059721LU	LT059721LU_ILD	GSM1150395	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 71	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 65	%predicted fvc (pre-bd): 67	%predicted dlco: 39	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150395/suppl/GSM1150395_LT059721LU_ILD.txt.gz	15261	NA	39	NA	65	NA	67	71	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	161195	Lung-LU	1-Male	71	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT061106RL	LT061106RL_ILD	GSM1150207	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	smoker?: 3-Never	%predicted fev1 (pre-bd): 75	%predicted fvc (pre-bd): 67	%predicted fev1 (post-bd): 77	%predicted fvc (post-bd): 74	%predicted dlco: 92	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150207/suppl/GSM1150207_LT061106RL_ILD.txt.gz	15261	NA	92	77	75	74	67	62	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	176141	Lung-RL	1-Male	62	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT062141RL	LT062141RL_ILD	GSM1150208	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	%emphysema (f-950): 2.436	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 83	%predicted fvc (pre-bd): 87	%predicted fev1 (post-bd): 81	%predicted fvc (post-bd): 84	%predicted dlco: 59	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150208/suppl/GSM1150208_LT062141RL_ILD.txt.gz	15261	2.436	59	81	83	84	87	72	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	211952	Lung-RL	1-Male	72	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	1-Yes	1-Yes	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT063974LL	LT063974LL_ILD	GSM1149993	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 58	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 42	%predicted fvc (pre-bd): 38	%predicted dlco: 26	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1149nnn/GSM1149993/suppl/GSM1149993_LT063974LL_ILD.txt.gz	15261	NA	26	NA	42	NA	38	58	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	157249	Lung-LL	2-Female	58	1-None	4-Evenly distributed	2-No	2-Ever (>100)	4-Diffuse	2-No	1-Yes	3-30-50%	2-No	1-Yes	2-No	2-No	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT067200LU	LT067200LU_ILD	GSM1150398	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 66	%emphysema (f-950): 0.051	smoker?: 3-Never	%predicted fev1 (pre-bd): 63	%predicted fvc (pre-bd): 58	%predicted fev1 (post-bd): 68	%predicted fvc (post-bd): 61	%predicted dlco: 46	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150398/suppl/GSM1150398_LT067200LU_ILD.txt.gz	15261	0.051	46	68	63	61	58	66	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	240030	Lung-LU	1-Male	66	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT067836RL	LT067836RL_ILD	GSM1150209	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	smoker?: 3-Never	%predicted fev1 (pre-bd): 42	%predicted fvc (pre-bd): 37	%predicted dlco: 26	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150209/suppl/GSM1150209_LT067836RL_ILD.txt.gz	15261	NA	26	NA	42	NA	37	69	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	171757	Lung-RL	1-Male	69			2-No	3-Never			2-No	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT076421LL	LT076421LL_ILD	GSM1150400	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 70	%emphysema (f-950): 0.015	smoker?: 3-Never	%predicted fev1 (pre-bd): 76	%predicted fvc (pre-bd): 69	%predicted dlco: 52	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150400/suppl/GSM1150400_LT076421LL_ILD.txt.gz	15261	0.015	52	NA	76	NA	69	70	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	204089	Lung-LL	2-Female	70	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	1-Yes	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT077264RU	LT077264RU_ILD	GSM1150401	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 73	%emphysema (f-950): 0.211	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 110	%predicted fvc (pre-bd): 93	%predicted dlco: 71	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150401/suppl/GSM1150401_LT077264RU_ILD.txt.gz	15261	0.211	71	NA	110	NA	93	73	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	104320	Lung-RU	2-Female	73	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	1->=80%	1-Yes	1-Yes	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT080750LL	LT080750LL_ILD	GSM1150404	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 70	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 115	%predicted fvc (pre-bd): 106	%predicted dlco: 51	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150404/suppl/GSM1150404_LT080750LL_ILD.txt.gz	15261	NA	51	NA	115	NA	106	70	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	77628	Lung-LL	1-Male	70	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT080836RL	LT080836RL_ILD	GSM1150221	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 54	%predicted fev1 (post-bd): 70	%predicted fvc (post-bd): 55	%predicted dlco: 56	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150221/suppl/GSM1150221_LT080836RL_ILD.txt.gz	15261	NA	56	70	69	55	54	65	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	102791	Lung-RL	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	3-Unknown	3-Unknown	3-Unknown	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT083491LU	LT083491LU_ILD	GSM1150004	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 56	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 85	%predicted fvc (pre-bd): 81	%predicted dlco: 55	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150004/suppl/GSM1150004_LT083491LU_ILD.txt.gz	15261	NA	55	NA	85	NA	81	56	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	83084	Lung-LU	1-Male	56	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT087826LL	LT087826LL_ILD	GSM1150410	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 66	smoker?: 3-Never	%predicted fev1 (pre-bd): 51	%predicted fvc (pre-bd): 47	%predicted dlco: 41	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150410/suppl/GSM1150410_LT087826LL_ILD.txt.gz	15261	NA	41	NA	51	NA	47	66	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	285079	Lung-LL	1-Male	66	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT089958RL	LT089958RL_ILD	GSM1150008	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	%emphysema (f-950): 0.289	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 81	%predicted fvc (pre-bd): 78	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150008/suppl/GSM1150008_LT089958RL_ILD.txt.gz	15261	0.289	NA	NA	81	NA	78	69	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	8949	Lung-RL	1-Male	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD			0-At Risk	IPF
LT090283LL	LT090283LL_ILD	GSM1150009	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	%emphysema (f-950): 1.506	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 88	%predicted fvc (pre-bd): 76	%predicted fev1 (post-bd): 80	%predicted fvc (post-bd): 73	%predicted dlco: 59	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150009/suppl/GSM1150009_LT090283LL_ILD.txt.gz	15261	1.506	59	80	88	73	76	62	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	71649	Lung-LL	1-Male	62	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	2-No	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT091552LL	LT091552LL_ILD	GSM1150412	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 60	%predicted fvc (pre-bd): 51	%predicted dlco: 52	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150412/suppl/GSM1150412_LT091552LL_ILD.txt.gz	15261	NA	52	NA	60	NA	51	72	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	57001	Lung-LL	1-Male	72	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT092669LU	LT092669LU_ILD	GSM1150010	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 70	%emphysema (f-950): 0.746	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 93	%predicted fvc (pre-bd): 75	%predicted dlco: 38	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150010/suppl/GSM1150010_LT092669LU_ILD.txt.gz	15261	0.746	38	NA	93	NA	75	70	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	197233	Lung-LU	2-Female	70	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	2-No	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT093665LI	LT093665LI_ILD	GSM1150011	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 64	%emphysema (f-950): 1.431	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 105	%predicted fvc (pre-bd): 96	%predicted dlco: 62	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150011/suppl/GSM1150011_LT093665LI_ILD.txt.gz	15261	1.431	62	NA	105	NA	96	64	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	146871	Lung-LI	1-Male	64	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT094217RM	LT094217RM_ILD	GSM1150229	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 44	%predicted fvc (pre-bd): 44	%predicted fev1 (post-bd): 72	%predicted fvc (post-bd): 65	%predicted dlco: 72	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150229/suppl/GSM1150229_LT094217RM_ILD.txt.gz	15261	NA	72	72	44	65	44	69	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	196170	Lung-RM	1-Male	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	1-Yes	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT098394RL	LT098394RL_ILD	GSM1150231	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	%predicted fev1 (pre-bd): 33	%predicted fvc (pre-bd): 27	ild subtype: 2-UIP/IPF							total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150231/suppl/GSM1150231_LT098394RL_ILD.txt.gz	15261	NA	NA	NA	33	NA	27	62	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	NA	IPF	288030	Lung-RL	1-Male	62								3-30-50%					1-ILD	1-ILD				IPF
LT099879RL	LT099879RL_ILD	GSM1150415	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 74	%emphysema (f-950): 0.014	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 99	%predicted fvc (pre-bd): 85	%predicted fev1 (post-bd): 101	%predicted fvc (post-bd): 85	%predicted dlco: 39	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150415/suppl/GSM1150415_LT099879RL_ILD.txt.gz	15261	0.014	39	101	99	85	85	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	269414	Lung-RL	2-Female	74	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)	0-At Risk	0-At Risk	IPF
LT100707RL	LT100707RL_ILD	GSM1150232	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 89	%predicted fvc (pre-bd): 87	%predicted fev1 (post-bd): 94	%predicted fvc (post-bd): 91	%predicted dlco: 60	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150232/suppl/GSM1150232_LT100707RL_ILD.txt.gz	15261	NA	60	94	89	91	87	68	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	42921	Lung-RL	1-Male	68	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant			1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT102695LL	LT102695LL_ILD	GSM1150418	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 59	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 73	%predicted fvc (pre-bd): 78	%predicted dlco: 44	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150418/suppl/GSM1150418_LT102695LL_ILD.txt.gz	15261	NA	44	NA	73	NA	78	59	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	57532	Lung-LL	2-Female	59	3-Central/Axial	1-None	2-No	2-Ever (>100)	1-None	2-No	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT103266RU	LT103266RU_ILD	GSM1150233	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 66	%predicted fvc (pre-bd): 63	%predicted fev1 (post-bd): 65	%predicted fvc (post-bd): 61	%predicted dlco: 67	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150233/suppl/GSM1150233_LT103266RU_ILD.txt.gz	15261	NA	67	65	66	61	63	68	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	146431	Lung-RU	1-Male	68	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT104717LL	LT104717LL_ILD	GSM1150018	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 37	%emphysema (f-950): 0.193	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 39	%predicted fvc (pre-bd): 37	%predicted dlco: 16	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150018/suppl/GSM1150018_LT104717LL_ILD.txt.gz	15261	0.193	16	NA	39	NA	37	37	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	190129	Lung-LL	1-Male	37	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT106997RU	LT106997RU_CTRL	GSM1150022	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 71	%emphysema (f-950): 0.203	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 104	%predicted fvc (pre-bd): 97	%predicted fev1 (post-bd): 102	%predicted fvc (post-bd): 95	%predicted dlco: 108		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150022/suppl/GSM1150022_LT106997RU_CTRL.txt.gz	15261	0.203	108	102	104	95	97	71	Control	0-At Risk	NA	NA	2-Female	3-Never	control	245562	Lung-RU	2-Female	71	1-None	1-None	2-No	3-Never	1-None		2-No	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT109321RL	LT109321RL_ILD	GSM1150024	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 65	%emphysema (f-950): 0.042	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 81	%predicted fvc (pre-bd): 72	%predicted dlco: 66	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150024/suppl/GSM1150024_LT109321RL_ILD.txt.gz	15261	0.042	66	NA	81	NA	72	65	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	176161	Lung-RL	2-Female	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT116004RL	LT116004RL_ILD	GSM1150421	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 50	smoker?: 3-Never	%predicted fev1 (pre-bd): 38	%predicted fvc (pre-bd): 40	%predicted dlco: 9	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150421/suppl/GSM1150421_LT116004RL_ILD.txt.gz	15261	NA	9	NA	38	NA	40	50	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	292282	Lung-RL	2-Female	50	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT123131RL	LT123131RL_ILD	GSM1150424	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 67	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 56	%predicted fvc (pre-bd): 47	%predicted fev1 (post-bd): 57	%predicted fvc (post-bd): 50	%predicted dlco: 34	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150424/suppl/GSM1150424_LT123131RL_ILD.txt.gz	15261	NA	34	57	56	50	47	67	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	164232	Lung-RL	1-Male	67	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT123552RL	LT123552RL_ILD	GSM1150425	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 74	ild subtype: 2-UIP/IPF									total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150425/suppl/GSM1150425_LT123552RL_ILD.txt.gz	15261	NA	NA	NA	NA	NA	NA	74	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	NA	IPF	278783	Lung-RL	1-Male	74													1-ILD	1-ILD				IPF
LT124161RL	LT124161RL_ILD	GSM1150426	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	smoker?: 3-Never	%predicted fev1 (pre-bd): 70	%predicted fvc (pre-bd): 62	%predicted dlco: 63	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150426/suppl/GSM1150426_LT124161RL_ILD.txt.gz	15261	NA	63	NA	70	NA	62	65	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	99075	Lung-RL	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT128191LL	LT128191LL_ILD	GSM1150428	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	%emphysema (f-950): 0.267	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 72	%predicted fvc (pre-bd): 65	%predicted dlco: 49	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150428/suppl/GSM1150428_LT128191LL_ILD.txt.gz	15261	0.267	49	NA	72	NA	65	62	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	95027	Lung-LL	1-Male	62	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT130603LL	LT130603LL_ILD	GSM1150429	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 63	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 56	%predicted fvc (pre-bd): 54	%predicted fev1 (post-bd): 59	%predicted fvc (post-bd): 53	%predicted dlco: 61	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150429/suppl/GSM1150429_LT130603LL_ILD.txt.gz	15261	NA	61	59	56	53	54	63	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	220767	Lung-LL	1-Male	63	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	2-Upper lobe predominant	1-Yes	1-Yes	2-50-80%	1-Yes	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT130861RU	LT130861RU_ILD	GSM1150244	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 68	%predicted fvc (pre-bd): 58	%predicted fev1 (post-bd): 72	%predicted fvc (post-bd): 60	%predicted dlco: 68	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150244/suppl/GSM1150244_LT130861RU_ILD.txt.gz	15261	NA	68	72	68	60	58	68	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	267101	Lung-RU	1-Male	68	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT131887LL	LT131887LL_ILD	GSM1150051	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 55	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 51	%predicted fvc (pre-bd): 44	%predicted dlco: 29	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150051/suppl/GSM1150051_LT131887LL_ILD.txt.gz	15261	NA	29	NA	51	NA	44	55	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	200428	Lung-LL	1-Male	55	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT132955RU	LT132955RU_CTRL	GSM1150053	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 1-Male	age: 63	%emphysema (f-950): 0.457	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 102	%predicted fvc (pre-bd): 93	%predicted dlco: 144				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150053/suppl/GSM1150053_LT132955RU_CTRL.txt.gz	15261	0.457	144	NA	102	NA	93	63	Control	0-At Risk	NA	NA	1-Male	2-Ever (>100)	control	153444	Lung-RU	1-Male	63	1-None	1-None	2-No	2-Ever (>100)	1-None	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)		0-At Risk	control
LT133029RM	LT133029RM_ILD	GSM1150054	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 71	%emphysema (f-950): 0.204	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 86	%predicted fvc (pre-bd): 76	%predicted fev1 (post-bd): 89	%predicted fvc (post-bd): 80	%predicted dlco: 51	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150054/suppl/GSM1150054_LT133029RM_ILD.txt.gz	15261	0.204	51	89	86	80	76	71	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	264154	Lung-RM	1-Male	71	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	3-Unknown	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT134279LL	LT134279LL_ILD	GSM1150245	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 59	smoker?: 3-Never	%predicted fev1 (pre-bd): 75	%predicted fvc (pre-bd): 69	%predicted fev1 (post-bd): 80	%predicted fvc (post-bd): 72	%predicted dlco: 95	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150245/suppl/GSM1150245_LT134279LL_ILD.txt.gz	15261	NA	95	80	75	72	69	59	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	213223	Lung-LL	1-Male	59	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant		2-No	2-50-80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT134776LL	LT134776LL_ILD	GSM1150431	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 62	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 71	%predicted fvc (pre-bd): 64	%predicted dlco: 61	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150431/suppl/GSM1150431_LT134776LL_ILD.txt.gz	15261	NA	61	NA	71	NA	64	62	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	205506	Lung-LL	2-Female	62	1-None	4-Evenly distributed	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT134829RL	LT134829RL_ILD	GSM1150247	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 71	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 83	%predicted fvc (pre-bd): 71	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150247/suppl/GSM1150247_LT134829RL_ILD.txt.gz	15261	NA	NA	NA	83	NA	71	71	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	287947	Lung-RL	1-Male	71	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	3-Unknown	3-Unknown	2-No	1-ILD	1-ILD			0-At Risk	IPF
LT135390LL	LT135390LL_ILD	GSM1150432	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 60	%emphysema (f-950): 5.934	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 77	%predicted fvc (pre-bd): 72	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150432/suppl/GSM1150432_LT135390LL_ILD.txt.gz	15261	5.934	NA	NA	77	NA	72	60	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	115950	Lung-LL	2-Female	60	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	3-Unknown	1-Yes	1-Yes	1-Yes	1-ILD	1-ILD				IPF
LT137431RL	LT137431RL_ILD	GSM1150056	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 53	%emphysema (f-950): 1.465	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 57	%predicted fvc (pre-bd): 53	%predicted dlco: 22	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150056/suppl/GSM1150056_LT137431RL_ILD.txt.gz	15261	1.465	22	NA	57	NA	53	53	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	274462	Lung-RL	1-Male	53	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT143944LL	LT143944LL_ILD	GSM1150436	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 74	%emphysema (f-950): 0.649	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 88	%predicted fvc (pre-bd): 78	%predicted dlco: 54	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150436/suppl/GSM1150436_LT143944LL_ILD.txt.gz	15261	0.649	54	NA	88	NA	78	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	145841	Lung-LL	1-Male	74	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT145196LU	LT145196LU_CTRL	GSM1150438	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 59	%emphysema (f-950): 0.136	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 89	%predicted fvc (pre-bd): 86	%predicted dlco: 89				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150438/suppl/GSM1150438_LT145196LU_CTRL.txt.gz	15261	0.136	89	NA	89	NA	86	59	Control	0-At Risk	NA	NA	2-Female	3-Never	control	227011	Lung-LU	2-Female	59	1-None	1-None	1-Yes	3-Never	1-None		2-No	1->=80%	1-Yes	3-Unknown	2-No	1-Yes	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)		0-At Risk	control
LT148511LU	LT148511LU_ILD	GSM1150256	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 45	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 64	%predicted fev1 (post-bd): 73	%predicted fvc (post-bd): 66	%predicted dlco: 43	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150256/suppl/GSM1150256_LT148511LU_ILD.txt.gz	15261	NA	43	73	69	66	64	45	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	NA	IPF	201549	Lung-LU	1-Male	45			2-No					2-50-80%					1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT151513LL	LT151513LL_ILD	GSM1150441	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 63	%emphysema (f-950): 0.331	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 70	%predicted fvc (pre-bd): 72	%predicted dlco: 47	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150441/suppl/GSM1150441_LT151513LL_ILD.txt.gz	15261	0.331	47	NA	70	NA	72	63	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	297193	Lung-LL	2-Female	63	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT152615RL	LT152615RL_ILD	GSM1150260	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 72	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 96	%predicted fvc (pre-bd): 92	%predicted fev1 (post-bd): 105	%predicted fvc (post-bd): 97	%predicted dlco: 81	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150260/suppl/GSM1150260_LT152615RL_ILD.txt.gz	15261	NA	81	105	96	97	92	72	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	11129	Lung-RL	2-Female	72	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT155318RL	LT155318RL_ILD	GSM1150442	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	%emphysema (f-950): 0.175	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 80	%predicted fvc (pre-bd): 73	%predicted fev1 (post-bd): 90	%predicted fvc (post-bd): 82	%predicted dlco: 65	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150442/suppl/GSM1150442_LT155318RL_ILD.txt.gz	15261	0.175	65	90	80	82	73	69	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	160060	Lung-RL	1-Male	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	2-No	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT156276RL	LT156276RL_ILD	GSM1150264	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 74	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 94	%predicted fvc (pre-bd): 75	%predicted fev1 (post-bd): 88	%predicted fvc (post-bd): 73	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150264/suppl/GSM1150264_LT156276RL_ILD.txt.gz	15261	NA	NA	88	94	73	75	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	27799	Lung-RL	2-Female	74	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD		0-At Risk	0-At Risk	IPF
LT156481LL	LT156481LL_CTRL	GSM1150444	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 60	gold stage: 0-At Risk	%predicted fev1 (pre-bd): 102	%predicted fvc (pre-bd): 103	%predicted fev1 (post-bd): 106	%predicted fvc (post-bd): 110	%predicted dlco: 84				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150444/suppl/GSM1150444_LT156481LL_CTRL.txt.gz	15261	NA	84	106	102	110	103	60	Control	0-At Risk	NA	NA	2-Female	NA	control	11631	Lung-LL	2-Female	60	3-Central/Axial	1-None			1-None			1->=80%					3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT157253RL	LT157253RL_ILD	GSM1150067	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 70	%emphysema (f-950): 0.016	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 63	%predicted fvc (pre-bd): 54	%predicted dlco: 41	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150067/suppl/GSM1150067_LT157253RL_ILD.txt.gz	15261	0.016	41	NA	63	NA	54	70	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	40550	Lung-RL	1-Male	70	2-Peripheral/Subpleural	4-Evenly distributed	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	1-Yes	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT158795LL	LT158795LL_ILD	GSM1150446	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	%emphysema (f-950): 0.012	smoker?: 3-Never	%predicted fev1 (pre-bd): 49	%predicted fvc (pre-bd): 43	%predicted dlco: 38	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150446/suppl/GSM1150446_LT158795LL_ILD.txt.gz	15261	0.012	38	NA	49	NA	43	62	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	85971	Lung-LL	1-Male	62	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	3-30-50%	3-Unknown	3-Unknown	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT159457LL	LT159457LL_ILD	GSM1150068	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 77	%predicted fvc (pre-bd): 62	%predicted dlco: 36	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150068/suppl/GSM1150068_LT159457LL_ILD.txt.gz	15261	NA	36	NA	77	NA	62	72	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	227690	Lung-LL	1-Male	72	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	2-Upper lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT161434RL	LT161434RL_ILD	GSM1150267	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 57	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 76	%predicted fvc (pre-bd): 79	%predicted fev1 (post-bd): 79	%predicted fvc (post-bd): 78	%predicted dlco: 68	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150267/suppl/GSM1150267_LT161434RL_ILD.txt.gz	15261	NA	68	79	76	78	79	57	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	122192	Lung-RL	1-Male	57	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT162096RL	LT162096RL_ILD	GSM1150448	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 69	%emphysema (f-950): 0.256	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 57	%predicted fvc (pre-bd): 55	%predicted dlco: 49	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150448/suppl/GSM1150448_LT162096RL_ILD.txt.gz	15261	0.256	49	NA	57	NA	55	69	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	264470	Lung-RL	2-Female	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT163384LL	LT163384LL_ILD	GSM1150449	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 60	%emphysema (f-950): 9.945	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 92	%predicted fvc (pre-bd): 85	%predicted dlco: 33	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150449/suppl/GSM1150449_LT163384LL_ILD.txt.gz	15261	9.945	33	NA	92	NA	85	60	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	5878	Lung-LL	1-Male	60	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	1-Yes	1-Yes	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT163513RL	LT163513RL_CTRL	GSM1150165	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 47	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 98	%predicted fvc (pre-bd): 85	%predicted fev1 (post-bd): 99	%predicted fvc (post-bd): 85	%predicted dlco: 104			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150165/suppl/GSM1150165_LT163513RL_CTRL.txt.gz	15261	NA	104	99	98	85	85	47	Control	0-At Risk	NA	NA	2-Female	3-Never	control	24991	Lung-RL	2-Female	47	1-None	1-None	1-Yes	3-Never	1-None		2-No	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT166111RU	LT166111RU_ILD	GSM1150451	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 77	gold stage: 0-At Risk	%predicted fev1 (pre-bd): 95	%predicted fvc (pre-bd): 80	%predicted fev1 (post-bd): 94	%predicted fvc (post-bd): 79	%predicted dlco: 51	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150451/suppl/GSM1150451_LT166111RU_ILD.txt.gz	15261	NA	51	94	95	79	80	77	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	NA	IPF	97900	Lung-RU	1-Male	77	1-None	2-Peripheral/Subpleural			3-Lower lobe predominant			1->=80%					1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT166493RM	LT166493RM_ILD	GSM1150073	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 74	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 87	%predicted fvc (pre-bd): 73	%predicted dlco: 68	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150073/suppl/GSM1150073_LT166493RM_ILD.txt.gz	15261	NA	68	NA	87	NA	73	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	144845	Lung-RM	2-Female	74	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT167906LL	LT167906LL_ILD	GSM1150454	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 58	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 60	%predicted dlco: 59	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150454/suppl/GSM1150454_LT167906LL_ILD.txt.gz	15261	NA	59	NA	69	NA	60	58	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	124951	Lung-LL	1-Male	58	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	2-No	1-Yes	2-50-80%	1-Yes	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT171169LU	LT171169LU_CTRL	GSM1150078	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 64	gold stage: 0-At Risk	%predicted fev1 (pre-bd): 87	%predicted fvc (pre-bd): 86	%predicted fev1 (post-bd): 89	%predicted fvc (post-bd): 90					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150078/suppl/GSM1150078_LT171169LU_CTRL.txt.gz	15261	NA	NA	89	87	90	86	64	Control	0-At Risk	NA	NA	2-Female	NA	control	211398	Lung-LU	2-Female	64	4-Evenly distributed	1-None			1-None			1->=80%					3-Control	3-Control		0-At Risk	0-At Risk	control
LT171905RL	LT171905RL_ILD	GSM1150079	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 59	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 105	%predicted fvc (pre-bd): 93	%predicted fev1 (post-bd): 107	%predicted fvc (post-bd): 96	%predicted dlco: 64	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150079/suppl/GSM1150079_LT171905RL_ILD.txt.gz	15261	NA	64	107	105	96	93	59	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	73460	Lung-RL	2-Female	59	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse		2-No	1->=80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT173946RL	LT173946RL_ILD	GSM1150460	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 70	%emphysema (f-950): 0.35	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 94	%predicted fvc (pre-bd): 82	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150460/suppl/GSM1150460_LT173946RL_ILD.txt.gz	15261	0.35	NA	NA	94	NA	82	70	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	101608	Lung-RL	2-Female	70	1-None	4-Evenly distributed	2-No	3-Never	4-Diffuse	2-No	2-No	1->=80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD			0-At Risk	IPF
LT174005RL	LT174005RL_CTRL	GSM1150081	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 44	gold stage: 0-At Risk	%predicted fev1 (pre-bd): 83	%predicted fvc (pre-bd): 88	%predicted fev1 (post-bd): 85	%predicted fvc (post-bd): 92	%predicted dlco: 88				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150081/suppl/GSM1150081_LT174005RL_CTRL.txt.gz	15261	NA	88	85	83	92	88	44	Control	0-At Risk	NA	NA	2-Female	NA	control	263966	Lung-RL	2-Female	44	1-None	1-None			1-None			1->=80%					3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT175399RU	LT175399RU_ILD	GSM1150461	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 64	%emphysema (f-950): 0.241	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 82	%predicted fvc (pre-bd): 69	%predicted dlco: 35	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150461/suppl/GSM1150461_LT175399RU_ILD.txt.gz	15261	0.241	35	NA	82	NA	69	64	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	89302	Lung-RU	2-Female	64	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT178986RU	LT178986RU_CTRL	GSM1150083	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 71	%emphysema (f-950): 0.097	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 83	%predicted fvc (pre-bd): 84					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150083/suppl/GSM1150083_LT178986RU_CTRL.txt.gz	15261	0.097	NA	NA	83	NA	84	71	Control	0-At Risk	NA	NA	2-Female	2-Ever (>100)	control	87534	Lung-RU	2-Female	71	1-None	1-None	2-No	2-Ever (>100)	1-None		2-No	1->=80%	2-No	2-No	2-No	1-Yes	3-Control	3-Control			0-At Risk	control
LT180758RM	LT180758RM_ILD	GSM1150084	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 58	%emphysema (f-950): 3.719	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 82	%predicted fvc (pre-bd): 86	%predicted fev1 (post-bd): 82	%predicted fvc (post-bd): 89	%predicted dlco: 58	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150084/suppl/GSM1150084_LT180758RM_ILD.txt.gz	15261	3.719	58	82	82	89	86	58	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	205214	Lung-RM	1-Male	58	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	2-Upper lobe predominant	1-Yes	1-Yes	1->=80%	1-Yes	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT180781RL	LT180781RL_ILD	GSM1150280	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 49	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 79	%predicted fvc (pre-bd): 63	%predicted fev1 (post-bd): 82	%predicted fvc (post-bd): 67	%predicted dlco: 46	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150280/suppl/GSM1150280_LT180781RL_ILD.txt.gz	15261	NA	46	82	79	67	63	49	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	61675	Lung-RL	2-Female	49	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	1-Yes	2-No	1-Yes	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT182636RU	LT182636RU_ILD	GSM1150281	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 66	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 63	%predicted fvc (pre-bd): 59	%predicted fev1 (post-bd): 69	%predicted fvc (post-bd): 59	%predicted dlco: 46	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150281/suppl/GSM1150281_LT182636RU_ILD.txt.gz	15261	NA	46	69	63	59	59	66	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	119520	Lung-RU	1-Male	66	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT185396RL	LT185396RL_ILD	GSM1150466	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 57	%emphysema (f-950): 0.195	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 78	%predicted fvc (pre-bd): 71	%predicted fev1 (post-bd): 83	%predicted fvc (post-bd): 72	%predicted dlco: 68	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150466/suppl/GSM1150466_LT185396RL_ILD.txt.gz	15261	0.195	68	83	78	72	71	57	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	99630	Lung-RL	1-Male	57	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT186388LL	LT186388LL_ILD	GSM1150467	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 74	%emphysema (f-950): 0.333	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 93	%predicted fvc (pre-bd): 76	%predicted fev1 (post-bd): 93	%predicted fvc (post-bd): 79	%predicted dlco: 45	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150467/suppl/GSM1150467_LT186388LL_ILD.txt.gz	15261	0.333	45	93	93	79	76	74	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	89321	Lung-LL	1-Male	74	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT187987LL	LT187987LL_ILD	GSM1150089	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	%emphysema (f-950): 1.139	smoker?: 3-Never	%predicted fev1 (pre-bd): 58	%predicted fvc (pre-bd): 52	%predicted dlco: 43	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150089/suppl/GSM1150089_LT187987LL_ILD.txt.gz	15261	1.139	43	NA	58	NA	52	72	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	233400	Lung-LL	1-Male	72	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse		2-No	2-50-80%	1-Yes	2-No	3-Unknown	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT188161LL	LT188161LL_ILD	GSM1150169	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 62	smoker?: 2-Ever (>100)	ild subtype: 2-UIP/IPF								total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150169/suppl/GSM1150169_LT188161LL_ILD.txt.gz	15261	NA	NA	NA	NA	NA	NA	62	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	246975	Lung-LL	2-Female	62	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No		2-No	2-No	3-Unknown	1-Yes	1-ILD	1-ILD				IPF
LT188524RL	LT188524RL_ILD	GSM1150286	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 45	smoker?: 3-Never	%predicted fev1 (pre-bd): 31	%predicted fvc (pre-bd): 28	ild subtype: 2-UIP/IPF						total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150286/suppl/GSM1150286_LT188524RL_ILD.txt.gz	15261	NA	NA	NA	31	NA	28	45	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	99807	Lung-RL	2-Female	45	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD				IPF
LT190870RU	LT190870RU_CTRL	GSM1150468	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 2-Female	age: 74	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 85	%predicted fvc (pre-bd): 90	%predicted fev1 (post-bd): 91	%predicted fvc (post-bd): 90	%predicted dlco: 103			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150468/suppl/GSM1150468_LT190870RU_CTRL.txt.gz	15261	NA	103	91	85	90	90	74	Control	0-At Risk	NA	NA	2-Female	3-Never	control	145856	Lung-RU	2-Female	74	1-None	1-None	2-No	3-Never	1-None		2-No	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT191675RL	LT191675RL_ILD	GSM1150470	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 69	%emphysema (f-950): 0.032	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 78	%predicted fvc (pre-bd): 77	%predicted dlco: 53	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150470/suppl/GSM1150470_LT191675RL_ILD.txt.gz	15261	0.032	53	NA	78	NA	77	69	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	155121	Lung-RL	2-Female	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT195192RL	LT195192RL_ILD	GSM1150094	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 57	%emphysema (f-950): 0.184	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 42	%predicted fvc (pre-bd): 40	%predicted dlco: 20	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150094/suppl/GSM1150094_LT195192RL_ILD.txt.gz	15261	0.184	20	NA	42	NA	40	57	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	208907	Lung-RL	2-Female	57	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT201348LL	LT201348LL_ILD	GSM1150480	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 65	%emphysema (f-950): 0.123	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 55	%predicted fvc (pre-bd): 47	%predicted dlco: 36	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150480/suppl/GSM1150480_LT201348LL_ILD.txt.gz	15261	0.123	36	NA	55	NA	47	65	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	137259	Lung-LL	2-Female	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT205601LL	LT205601LL_ILD	GSM1150100	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 56	%emphysema (f-950): 0.141	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 58	%predicted fvc (pre-bd): 51	%predicted dlco: 39	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150100/suppl/GSM1150100_LT205601LL_ILD.txt.gz	15261	0.141	39	NA	58	NA	51	56	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	282725	Lung-LL	1-Male	56	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT206005RL	LT206005RL_ILD	GSM1150302	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 68	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 79	%predicted fvc (pre-bd): 72	ild subtype: 2-UIP/IPF						total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150302/suppl/GSM1150302_LT206005RL_ILD.txt.gz	15261	NA	NA	NA	79	NA	72	68	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	50887	Lung-RL	1-Male	68	1-None	4-Evenly distributed	2-No	2-Ever (>100)	4-Diffuse	2-No	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD				IPF
LT207073RU	LT207073RU_ILD	GSM1150484	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 66	%emphysema (f-950): 0.416	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 60	%predicted fvc (pre-bd): 54	%predicted dlco: 36	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150484/suppl/GSM1150484_LT207073RU_ILD.txt.gz	15261	0.416	36	NA	60	NA	54	66	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	193879	Lung-RU	1-Male	66	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT211379RL	LT211379RL_ILD	GSM1150306	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 53	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 68	%predicted fvc (pre-bd): 61	%predicted fev1 (post-bd): 70	%predicted fvc (post-bd): 63	%predicted dlco: 60	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150306/suppl/GSM1150306_LT211379RL_ILD.txt.gz	15261	NA	60	70	68	63	61	53	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	250391	Lung-RL	1-Male	53	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	1-Yes	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT211455LU	LT211455LU_ILD	GSM1150104	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 64	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 82	%predicted fvc (pre-bd): 72	%predicted dlco: 67	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150104/suppl/GSM1150104_LT211455LU_ILD.txt.gz	15261	NA	67	NA	82	NA	72	64	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	51831	Lung-LU	1-Male	64	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse			1->=80%	2-No	1-Yes	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT219681RL	LT219681RL_ILD	GSM1150108	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 62	%emphysema (f-950): 7.246	gold stage: 3-Severe COPD	smoker?: 3-Never	%predicted fev1 (pre-bd): 36	%predicted fvc (pre-bd): 43	%predicted fev1 (post-bd): 41	%predicted fvc (post-bd): 51	%predicted dlco: 30	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150108/suppl/GSM1150108_LT219681RL_ILD.txt.gz	15261	7.246	30	41	36	51	43	62	Interstitial lung disease	3-Severe COPD	2-UIP/IPF	NA	2-Female	3-Never	IPF	91	Lung-RL	2-Female	62	1-None	2-Peripheral/Subpleural	1-Yes	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	3-30-50%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)	3-Severe COPD	3-Severe COPD	IPF
LT220661RL	LT220661RL_ILD	GSM1150487	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 52	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 57	%predicted fvc (pre-bd): 52	%predicted dlco: 29	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150487/suppl/GSM1150487_LT220661RL_ILD.txt.gz	15261	NA	29	NA	57	NA	52	52	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	218651	Lung-RL	1-Male	52	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	2-No	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT221381RL	LT221381RL_ILD	GSM1150488	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 65	smoker?: 2-Ever (>100)	ild subtype: 2-UIP/IPF								total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150488/suppl/GSM1150488_LT221381RL_ILD.txt.gz	15261	NA	NA	NA	NA	NA	NA	65	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	276264	Lung-RL	2-Female	65			2-No	2-Ever (>100)		1-Yes	1-Yes		2-No	2-No	2-No	1-Yes	1-ILD	1-ILD				IPF
LT223474RM	LT223474RM_ILD	GSM1150313	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 74	%predicted fvc (pre-bd): 70	%predicted fev1 (post-bd): 74	%predicted fvc (post-bd): 63	%predicted dlco: 49	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150313/suppl/GSM1150313_LT223474RM_ILD.txt.gz	15261	NA	49	74	74	63	70	65	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	24709	Lung-RM	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse		2-No	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT228897LL	LT228897LL_ILD	GSM1150495	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 63	%emphysema (f-950): 0.031	smoker?: 3-Never	%predicted fev1 (pre-bd): 70	%predicted fvc (pre-bd): 62	%predicted dlco: 50	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150495/suppl/GSM1150495_LT228897LL_ILD.txt.gz	15261	0.031	50	NA	70	NA	62	63	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	117436	Lung-LL	1-Male	63	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT230142RL	LT230142RL_ILD	GSM1150111	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 78	%predicted fvc (pre-bd): 72	%predicted dlco: 41	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150111/suppl/GSM1150111_LT230142RL_ILD.txt.gz	15261	NA	41	NA	78	NA	72	72	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	239446	Lung-RL	1-Male	72	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT231373LU	LT231373LU_ILD	GSM1150173	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 67	smoker?: 3-Never	%predicted fev1 (pre-bd): 75	%predicted fvc (pre-bd): 60	%predicted fev1 (post-bd): 74	%predicted fvc (post-bd): 60	%predicted dlco: 41	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150173/suppl/GSM1150173_LT231373LU_ILD.txt.gz	15261	NA	41	74	75	60	60	67	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	288800	Lung-LU	1-Male	67	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT232073LU	LT232073LU_ILD	GSM1150497	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 69	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 58	%predicted dlco: 43	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150497/suppl/GSM1150497_LT232073LU_ILD.txt.gz	15261	NA	43	NA	69	NA	58	69	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	64526	Lung-LU	1-Male	69	1-None	4-Evenly distributed	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT235441RL	LT235441RL_ILD	GSM1150503	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 69	%emphysema (f-950): 2.073	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 85	%predicted fvc (pre-bd): 82	%predicted dlco: 50	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150503/suppl/GSM1150503_LT235441RL_ILD.txt.gz	15261	2.073	50	NA	85	NA	82	69	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	226029	Lung-RL	2-Female	69	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	1->=80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT236045LL	LT236045LL_ILD	GSM1150504	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 78	%emphysema (f-950): 0.203	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 67	%predicted fvc (pre-bd): 60	%predicted dlco: 48	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150504/suppl/GSM1150504_LT236045LL_ILD.txt.gz	15261	0.203	48	NA	67	NA	60	78	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	216199	Lung-LL	1-Male	78	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	2-No	2-No	2-50-80%	1-Yes	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT242161RL	LT242161RL_ILD	GSM1150510	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 60	smoker?: 3-Never	%predicted fev1 (pre-bd): 77	%predicted fvc (pre-bd): 68	%predicted fev1 (post-bd): 80	%predicted fvc (post-bd): 71	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150510/suppl/GSM1150510_LT242161RL_ILD.txt.gz	15261	NA	NA	80	77	71	68	60	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	177645	Lung-RL	2-Female	60	1-None	4-Evenly distributed	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD				IPF
LT244824RU	LT244824RU_ILD	GSM1150513	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 72	%emphysema (f-950): 0.142	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 80	%predicted fvc (pre-bd): 77	%predicted fev1 (post-bd): 83	%predicted fvc (post-bd): 76	%predicted dlco: 41	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150513/suppl/GSM1150513_LT244824RU_ILD.txt.gz	15261	0.142	41	83	80	76	77	72	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	2-Ever (>100)	IPF	55559	Lung-RU	2-Female	72	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	3-Unknown	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT249481LU	LT249481LU_ILD	GSM1150519	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	%emphysema (f-950): 0.891	smoker?: 1-Current	%predicted fev1 (pre-bd): 74	%predicted fvc (pre-bd): 65	%predicted dlco: 51	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150519/suppl/GSM1150519_LT249481LU_ILD.txt.gz	15261	0.891	51	NA	74	NA	65	65	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	1-Current	IPF	46524	Lung-LU	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	1-Current	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT250549RL	LT250549RL_ILD	GSM1150118	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 61	smoker?: 3-Never	%predicted fev1 (pre-bd): 54	%predicted fvc (pre-bd): 43	%predicted dlco: 23	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150118/suppl/GSM1150118_LT250549RL_ILD.txt.gz	15261	NA	23	NA	54	NA	43	61	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	117551	Lung-RL	1-Male	61	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT253677RL	LT253677RL_ILD	GSM1150525	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 54	%emphysema (f-950): 0.255	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 77	%predicted fvc (pre-bd): 77	%predicted dlco: 64	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150525/suppl/GSM1150525_LT253677RL_ILD.txt.gz	15261	0.255	64	NA	77	NA	77	54	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	109891	Lung-RL	1-Male	54	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT258372RL	LT258372RL_ILD	GSM1150119	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 64	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 55	%predicted fvc (pre-bd): 48	ild subtype: 2-UIP/IPF						total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150119/suppl/GSM1150119_LT258372RL_ILD.txt.gz	15261	NA	NA	NA	55	NA	48	64	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	134977	Lung-RL	1-Male	64	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD				IPF
LT263234RL	LT263234RL_ILD	GSM1150121	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 58	%emphysema (f-950): 8.889	smoker?: 3-Never	%predicted fev1 (pre-bd): 43	%predicted fvc (pre-bd): 40	%predicted dlco: 22	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150121/suppl/GSM1150121_LT263234RL_ILD.txt.gz	15261	8.889	22	NA	43	NA	40	58	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	135461	Lung-RL	1-Male	58	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	2-No	2-No	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT264690LU	LT264690LU_ILD	GSM1150122	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 81	%predicted fvc (pre-bd): 82	%predicted dlco: 27	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150122/suppl/GSM1150122_LT264690LU_ILD.txt.gz	15261	NA	27	NA	81	NA	82	65	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	47167	Lung-LU	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	1->=80%	3-Unknown	3-Unknown	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT266802RL	LT266802RL_ILD	GSM1150354	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 58	smoker?: 3-Never	%predicted fev1 (pre-bd): 69	%predicted fvc (pre-bd): 61	%predicted fev1 (post-bd): 66	%predicted fvc (post-bd): 59	%predicted dlco: 60	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150354/suppl/GSM1150354_LT266802RL_ILD.txt.gz	15261	NA	60	66	69	59	61	58	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	71161	Lung-RL	1-Male	58	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	1-Yes	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT266817LL	LT266817LL_ILD	GSM1150530	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 65	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 59	%predicted fvc (pre-bd): 50	%predicted fev1 (post-bd): 51	%predicted fvc (post-bd): 48	%predicted dlco: 44	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150530/suppl/GSM1150530_LT266817LL_ILD.txt.gz	15261	NA	44	51	59	48	50	65	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	274936	Lung-LL	1-Male	65	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	2-No	2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT269381RU	LT269381RU_ILD	GSM1150125	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 50	%emphysema (f-950): 0.012	gold stage: 3-Severe COPD	smoker?: 3-Never	%predicted fev1 (pre-bd): 54	%predicted fvc (pre-bd): 56	%predicted fev1 (post-bd): 47	%predicted fvc (post-bd): 54	%predicted dlco: 46	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150125/suppl/GSM1150125_LT269381RU_ILD.txt.gz	15261	0.012	46	47	54	54	56	50	Interstitial lung disease	3-Severe COPD	2-UIP/IPF	NA	2-Female	3-Never	IPF	65647	Lung-RU	2-Female	50	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	3-Severe COPD	3-Severe COPD	IPF
LT269763RL	LT269763RL_ILD	GSM1150356	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 56	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 82	%predicted fvc (pre-bd): 80	%predicted dlco: 18	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150356/suppl/GSM1150356_LT269763RL_ILD.txt.gz	15261	NA	18	NA	82	NA	80	56	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	22285	Lung-RL	1-Male	56	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	2-No	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)		0-At Risk	IPF
LT275526RU	LT275526RU_ILD	GSM1150130	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 49	%emphysema (f-950): 0.439	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 49	%predicted fvc (pre-bd): 48	%predicted fev1 (post-bd): 52	%predicted fvc (post-bd): 52	ild subtype: 2-UIP/IPF			total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150130/suppl/GSM1150130_LT275526RU_ILD.txt.gz	15261	0.439	NA	52	49	52	48	49	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	273341	Lung-RU	1-Male	49	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	3-30-50%	2-No	2-No	2-No	2-No	1-ILD	1-ILD				IPF
LT275856LL	LT275856LL_ILD	GSM1150360	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 63	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 66	%predicted fvc (pre-bd): 62	%predicted dlco: 26	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150360/suppl/GSM1150360_LT275856LL_IDL.txt.gz	15261	NA	26	NA	66	NA	62	63	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	188601	Lung-LL	1-Male	63	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT277772LL	LT277772LL_ILD	GSM1150132	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 61	smoker?: 3-Never	%predicted fev1 (pre-bd): 41	%predicted fvc (pre-bd): 32	ild subtype: 2-UIP/IPF						total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150132/suppl/GSM1150132_LT277772LL_ILD.txt.gz	15261	NA	NA	NA	41	NA	32	61	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	3-Never	IPF	257122	Lung-LL	1-Male	61	1-None	4-Evenly distributed	2-No	3-Never	3-Lower lobe predominant		2-No	3-30-50%	2-No	2-No	2-No	2-No	1-ILD	1-ILD				IPF
LT277811RL	LT277811RL_ILD	GSM1150532	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 82	%emphysema (f-950): 3.623	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 104	%predicted fvc (pre-bd): 89	%predicted fev1 (post-bd): 106	%predicted fvc (post-bd): 88	%predicted dlco: 50	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150532/suppl/GSM1150532_LT277811RL_ILD.txt.gz	15261	3.623	50	106	104	88	89	82	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	154914	Lung-RL	1-Male	82	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT279828RU	LT279828RU_ILD	GSM1150533	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 72	%emphysema (f-950): 0.793	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 68	%predicted fvc (pre-bd): 58	%predicted dlco: 36	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150533/suppl/GSM1150533_LT279828RU_ILD.txt.gz	15261	0.793	36	NA	68	NA	58	72	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	72607	Lung-RU	1-Male	72	4-Evenly distributed	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT280282RL	LT280282RL_ILD	GSM1150534	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 80	%emphysema (f-950): 0.046	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 68	%predicted fvc (pre-bd): 52	%predicted dlco: 32	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150534/suppl/GSM1150534_LT280282RL_ILD.txt.gz	15261	0.046	32	NA	68	NA	52	80	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	217783	Lung-RL	1-Male	80	1-None	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant		2-No	2-50-80%	2-No	2-No	2-No	2-No	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT280851LL	LT280851LL_ILD	GSM1150535	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 65	%emphysema (f-950): 0.174	smoker?: 3-Never	%predicted fev1 (pre-bd): 66	%predicted fvc (pre-bd): 54	%predicted fev1 (post-bd): 67	%predicted fvc (post-bd): 56	%predicted dlco: 33	ild subtype: 2-UIP/IPF		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150535/suppl/GSM1150535_LT280851LL_ILD.txt.gz	15261	0.174	33	67	66	56	54	65	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	27727	Lung-LL	2-Female	65	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	2-No	2-No	2-50-80%	2-No	2-No	1-Yes	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT282601LL	LT282601LL_ILD	GSM1150536	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 60	smoker?: 3-Never	%predicted fev1 (pre-bd): 51	%predicted fvc (pre-bd): 45	%predicted dlco: 31	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150536/suppl/GSM1150536_LT282601LL_ILD.txt.gz	15261	NA	31	NA	51	NA	45	60	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	238014	Lung-LL	2-Female	60	1-None	4-Evenly distributed	2-No	3-Never	3-Lower lobe predominant	2-No	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT286300LU	LT286300LU_CTRL	GSM1150176	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Control	Sex: 1-Male	age: 45	%emphysema (f-950): 4.03	gold stage: 0-At Risk	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 89	%predicted fvc (pre-bd): 86	%predicted fev1 (post-bd): 91	%predicted fvc (post-bd): 87	%predicted dlco: 71		total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150176/suppl/GSM1150176_LT286300LU_CTRL.txt.gz	15261	4.03	71	91	89	87	86	45	Control	0-At Risk	NA	NA	1-Male	2-Ever (>100)	control	271296	Lung-LU	1-Male	45	1-None	1-None	2-No	2-Ever (>100)	1-None		2-No	1->=80%	2-No	2-No	2-No	2-No	3-Control	3-Control	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	control
LT288719RL	LT288719RL_ILD	GSM1150542	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 80	%emphysema (f-950): 0.182	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 91	%predicted fvc (pre-bd): 75	%predicted fev1 (post-bd): 96	%predicted fvc (post-bd): 76	%predicted dlco: 67	ild subtype: 2-UIP/IPF	total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150542/suppl/GSM1150542_LT288719RL_ILD.txt.gz	15261	0.182	67	96	91	76	75	80	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	1-Male	3-Never	IPF	106322	Lung-RL	1-Male	80	1-None	2-Peripheral/Subpleural	2-No	3-Never	4-Diffuse	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)	0-At Risk	0-At Risk	IPF
LT295133LL	LT295133LL_ILD	GSM1150177	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 57	%emphysema (f-950): 0.356	smoker?: 3-Never	%predicted fev1 (pre-bd): 63	%predicted fvc (pre-bd): 58	%predicted dlco: 60	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150177/suppl/GSM1150177_LT295133LL_ILD.txt.gz	15261	0.356	60	NA	63	NA	58	57	Interstitial lung disease	NA	2-UIP/IPF	NA	2-Female	3-Never	IPF	146848	Lung-LL	2-Female	57	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	2-50-80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)			IPF
LT295717RL	LT295717RL_ILD	GSM1150545	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 71	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 90	%predicted fvc (pre-bd): 75	%predicted dlco: 65	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150545/suppl/GSM1150545_LT295717RL_ILD.txt.gz	15261	NA	65	NA	90	NA	75	71	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	84650	Lung-RL	2-Female	71	1-None	2-Peripheral/Subpleural	2-No	3-Never	2-Upper lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
LT296771LL	LT296771LL_ILD	GSM1150142	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 1-Male	age: 62	smoker?: 2-Ever (>100)	%predicted fev1 (pre-bd): 50	%predicted fvc (pre-bd): 49	%predicted dlco: 15	ild subtype: 2-UIP/IPF					total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL6480	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150142/suppl/GSM1150142_LT296771LL_ILD.txt.gz	15261	NA	15	NA	50	NA	49	62	Interstitial lung disease	NA	2-UIP/IPF	NA	1-Male	2-Ever (>100)	IPF	169492	Lung-LL	1-Male	62	2-Peripheral/Subpleural	2-Peripheral/Subpleural	2-No	2-Ever (>100)	3-Lower lobe predominant	2-No	2-No	3-30-50%	2-No	2-No	2-No	1-Yes	1-ILD	1-ILD	1-Advanced Disease (DLCO < 40%)			IPF
LT297451LU	LT297451LU_ILD	GSM1150546	Public on May 30 2013	May 29 2013	May 30 2013	RNA	1	Flash frozen whole lung	Homo sapiens	disease state: Interstitial lung disease	Sex: 2-Female	age: 71	gold stage: 0-At Risk	smoker?: 3-Never	%predicted fev1 (pre-bd): 99	%predicted fvc (pre-bd): 90	%predicted dlco: 87	ild subtype: 2-UIP/IPF				total RNA	30 mg of whole lung was homogenized with Trizol and then total RNA was extracted using the QiaCube system (Qiagen, Valencia CA).  RNA quality was determined by Agilent Bioanalyzer 2100 (Agilent Technologies Inc, Santa Clara, CA) with RIN > 7.0 being acceptable for microarray usage.	Cy3	Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the QuickAmp kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.	9606	1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was hybridized to the specified arrays as per manufacturer instructions.  Hybridization was in a rotating oven at the specified temperature	Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44K arrays or 8x60K arrays as noted	The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default perameters to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.  The resulting array data was normalized using a cyclic loess approach in pairwise fashion.  Probes were then collapsed to one gene/one probe by highest signal intensity.	GPL14550	John,,Tedrow	jrtedrow@gmail.com	4128028524	Internal Medicine	University of Pittsburgh	3471 Fifth Avenue, Suite 1211	Pittsburgh	PA	15213	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1150nnn/GSM1150546/suppl/GSM1150546_LT297451LU_ILD.txt.gz	15261	NA	87	NA	99	NA	90	71	Interstitial lung disease	0-At Risk	2-UIP/IPF	NA	2-Female	3-Never	IPF	276374	Lung-LU	2-Female	71	1-None	2-Peripheral/Subpleural	2-No	3-Never	3-Lower lobe predominant	1-Yes	1-Yes	1->=80%	2-No	2-No	1-Yes	2-No	1-ILD	1-ILD	2-Limited Disease (DLCO >= 40%)		0-At Risk	IPF
